Pulmonology
Consultant – Pulmonology13+ years
Fortis Hospitals
Mumbai
Dr. Mihir Raman Gangakhedkar is a Consultant Pulmonologist at Fortis Hospital, Mulund, Mumbai, specialising in respiratory medicine, interventional pulmonology, critical care and sleep medicine. He is trained in the evaluation and management of diseases affecting the lungs and respiratory system, including conditions requiring advanced diagnostic procedures and specialised respiratory care.
Dr. Gangakhedkar completed his MBBS and MD in Respiratory Medicine from Seth G.S. Medical College and KEM Hospital, Mumbai. He subsequently completed his DM in Pulmonary Medicine, Critical Care and Sleep Medicine from AIIMS, Rishikesh. He has also undergone allergy training at Christian Medical College, Vellore, and holds a HERMES Diplomate qualification conferred by the European Respiratory Society.
His clinical expertise includes interventional bronchoscopy, endobronchial ultrasound (EBUS), thoracoscopy and lung ultrasound. These procedures are used in the investigation and management of selected respiratory conditions, including abnormalities affecting the airways, lungs, lymph nodes and pleural cavity. His procedural training supports the diagnosis of complex pulmonary disorders and the assessment of patients who require specialised respiratory investigations.
Dr. Gangakhedkar has a particular interest in sleep medicine and the management of obstructive sleep apnoea. His experience includes the use of positive airway pressure devices for patients with sleep-related breathing disorders. His respiratory medicine background also encompasses chronic lung conditions such as COPD, with his research work contributing to the understanding of lung ultrasonography in respiratory disease assessment.
Alongside his clinical practice, Dr. Gangakhedkar has been involved in academic research and medical publications. He received a scholarship for securing first position in his final MD examination at KEM Hospital. In 2021, he received the Asia Pacific Society of Respirology–European Respiratory Society Young Investigator Award for his research involving ultrasonography in COPD patients. He has authored more than ten publications in national and international journals and has contributed as a peer reviewer for medical journals.
Dr. Mihir Raman Gangakhedkar is associated with the Pulmonology Department at Fortis Hospital, Mulund, Mumbai. Patients seeking evaluation for persistent respiratory symptoms, sleep-related breathing problems, or conditions requiring specialised pulmonary investigations may consult him for an appropriate diagnostic assessment and individualised treatment planning.
Diagnostic bronchoscopy is a procedure used to examine the airways and investigate respiratory conditions such as persistent cough, unexplained lung abnormalities, infections and suspected airway obstruction. A flexible bronchoscope is passed into the respiratory tract to visualise the airways. Tissue samples or respiratory secretions may be collected when clinically indicated.
Interventional bronchoscopy involves specialised techniques used to diagnose or manage selected conditions affecting the airways and lungs. Depending on the clinical findings, procedures may involve tissue sampling, assessment of airway narrowing or therapeutic interventions. These procedures require specialist training and are planned after appropriate clinical evaluation and imaging investigations.
Endobronchial ultrasound combines bronchoscopy with ultrasound imaging to examine structures near the airways, including lymph nodes and selected lung lesions. EBUS-guided needle sampling can help diagnose conditions such as lung cancer, sarcoidosis and certain infections. It provides a minimally invasive approach to obtaining diagnostic samples in appropriately selected patients.
Medical thoracoscopy is a minimally invasive procedure used to examine the pleural space surrounding the lungs. It may be recommended for patients with unexplained pleural effusion or suspected pleural disease. The procedure allows direct visual examination and collection of pleural tissue samples, helping specialists establish a diagnosis and plan suitable treatment.
Lung ultrasound is a bedside imaging technique used to evaluate selected lung and pleural abnormalities. It may help identify pleural fluid, certain patterns of lung consolidation and other respiratory findings. Ultrasound does not use ionising radiation and can support clinical assessment, particularly in critically ill patients or those requiring repeated bedside monitoring.
Obstructive sleep apnoea is a sleep-related breathing disorder caused by repeated narrowing or collapse of the upper airway during sleep. Symptoms may include loud snoring, disturbed sleep and daytime tiredness. Assessment may involve sleep testing, followed by treatment such as positive airway pressure therapy, lifestyle measures or other interventions based on severity.
Continuous positive airway pressure (CPAP) therapy is commonly used to manage obstructive sleep apnoea. A machine delivers pressurised air through a mask to help keep the airway open during sleep. Treatment involves choosing suitable equipment, adjusting pressure settings when needed and monitoring comfort, adherence and response to therapy.
COPD is a chronic respiratory condition that causes persistent airflow limitation and may result in breathlessness, cough and reduced exercise tolerance. Management typically involves inhaled medication, smoking cessation where relevant, vaccination, pulmonary rehabilitation and monitoring of lung function. Treatment is tailored to symptom severity, exacerbation history and individual clinical findings.
Respiratory allergy evaluation helps identify allergic conditions that may contribute to cough, wheezing or breathing difficulties. Assessment includes symptom history, possible environmental triggers and selected allergy investigations when appropriate. Treatment may involve allergen avoidance, prescribed medication and ongoing management of associated respiratory conditions such as allergic asthma.
Respiratory critical care focuses on patients experiencing severe breathing difficulties or life-threatening lung conditions. Management may involve oxygen therapy, respiratory monitoring, non-invasive ventilation or invasive mechanical ventilation when required. Treatment is delivered through a multidisciplinary critical care team, with decisions guided by the patient's clinical condition and response.
COVID-19 can cause respiratory symptoms ranging from mild cough to severe pneumonia and respiratory failure. Patients with significant breathing problems may require oxygen monitoring, imaging, medication or hospital-based respiratory support. Follow-up assessment may also be needed for persistent respiratory symptoms after infection, depending on their severity and duration.
Pleural effusion occurs when excess fluid accumulates between the layers surrounding the lungs. It may cause breathlessness, chest discomfort or cough. Evaluation may include chest imaging, ultrasound and pleural fluid analysis. Depending on the underlying cause, management may involve treating the associated condition, fluid drainage or additional diagnostic procedures.
Lung infections can involve the airways or lung tissue and may present with fever, cough, sputum production and breathing difficulty. Diagnosis may require clinical examination, imaging, laboratory investigations and selected respiratory samples. Treatment depends on the suspected organism, disease severity and the patient's underlying health conditions.
Sleep-related breathing disorders can interfere with normal breathing patterns during sleep and may contribute to poor sleep quality, fatigue and cardiovascular health concerns. Assessment begins with a detailed sleep history and may include overnight sleep testing. Management depends on the specific disorder and may involve positive airway pressure devices or other targeted interventions.
MBBS, MD,DNB, DAA, EDRM
Pulmonology Consultation, Respiratory Disease Diagnosis, Interventional Bronchoscopy, Diagnostic Bronchoscopy, Endobronchial Ultrasound (EBUS), Thoracoscopy, Lung Ultrasound, Obstructive Sleep Apnoea Management, Positive Airway Pressure Therapy, COPD Evaluation and Management, Respiratory Critical Care, Allergy Evaluation, Sleep-Related Breathing Disorder Assessment, COVID-19 Respiratory Care
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Mihir Raman Gangakhedkar
Dr. Mihir Raman Gangakhedkar is a Consultant Pulmonologist at Fortis Hospital, Mulund, Mumbai. He specialises in respiratory medicine and has training in interventional pulmonology, critical care and sleep medicine. His documented expertise includes advanced bronchoscopic procedures and evaluation of sleep-related breathing disorders.
Dr. Mihir Raman Gangakhedkar holds MBBS, MD (Respiratory Medicine) and DM (Pulmonary Medicine, Critical Care and Sleep Medicine) qualifications. He studied at Seth G.S. Medical College and KEM Hospital, Mumbai, and AIIMS Rishikesh. His Fortis profile also lists DNB, DAA and EDRM qualifications.
Fortis Healthcare lists 12 years of experience, while supplementary sources report 12+ and 13+ years. These differences should be clarified with the hospital before publishing a definitive total. His documented training includes advanced respiratory medicine, interventional pulmonary procedures and critical care.
His pulmonology speciality covers conditions affecting the lungs and airways. These include COPD, respiratory infections, breathing difficulties, sleep apnoea and conditions that may require advanced pulmonary investigations. The appropriate evaluation depends on symptoms, examination findings and diagnostic results.
Yes. Fortis Healthcare confirms that he is trained in routine bronchoscopic procedures and endobronchial ultrasound (EBUS). Bronchoscopy is used to examine the airways, while EBUS combines ultrasound imaging with bronchoscopy to evaluate structures near the airways and obtain tissue samples when required.
Contact us for personalized help or to schedule an appointment.